2nd Edition of Transport of High Risk Neonates
 

ABSTRACT SUBISSION GUIDELINES

SUBMISSION DEADLINE CLOSED


ABSTRACT PREPARATION

Before you begin, please prepare the following information:

1.    Presenting author's and Co-authors' details
Full first and family name(s).
Affiliation details: department, institution / hospital, city, state (if relevant), country, email address

2.    Abstract title – limited to 25 words in UPPER CASE

3.    Abstract text – limited to 250 words, including acknowledgements. We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.

4.    Abstracts should clearly state:
· Background and aims
· Methods
· Results
· Conclusions

5.    Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appears the first time.

6.    Use generic names of drugs. Express numbers as numerals.

7.    Abstract Topics – abstracts must be allocated to a specific category for the Scientific Programme. You will need to select the category most suited to your abstract. Tables – A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract.

8.    Graphs and Images – A maximum of 2 images can be included per abstract. The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. Graphs and images may be uploaded in JPG, PNG and GIF format only. When including a table it is recommended to save the table as an image and then upload it in to the abstract.

9.    After you submit your abstract, you can re-enter the submission link at any time to view and edit your abstract until the deadline date. Submitted abstracts cannot be modified or corrected after the submission deadline. There is no option to save the abstract as draft and to submit it at a later stage. If you do not submit your abstract, the information will be deleted.

 

ABSTRACT PUBLICATION

Accepted abstracts will be published in a​​n online journal and on the Congress website.


DISCLOSURE

Disclosure of financial relationships that the author(s) may have with the manufacturer/supplier of any commercial products or services related to the work, should be indicated in the appropriate box on the abstract form.

 

ABSTRACT SELECTION AND PRESENTATION

Participants interested in presenting an oral or e-poster presentation are invited to submit an abstract. All abstracts will undergo review by Scientific Committee. The Committee will determine whether abstracts will be accepted as oral or e-poster presentations with consideration to be given to the author's preference. All abstracts will be reviewed by the Scientific Committee. Submitting authors will be notified via e-mail by the first week of August, 2016 regarding the status of their abstract acceptance.